Cargando…
COVID-19 infection causes a reduction in neutrophil counts in patients taking clozapine
BACKGROUND: Monitoring of white cell counts during clozapine treatment leads to cessation of therapy if levels fall below pre-determined values. Reductions in white cell counts, driven by lower levels of lymphocytes, have been observed with coronavirus disease 2019 (COVID-19). Neutropenia during COV...
Autores principales: | Gee, Siobhan, Taylor, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Joule Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061743/ https://www.ncbi.nlm.nih.gov/pubmed/33703870 http://dx.doi.org/10.1503/jpn.200208 |
Ejemplares similares
-
The effect of COVID-19 on absolute neutrophil counts in patients
taking clozapine
por: Gee, Siobhan, et al.
Publicado: (2020) -
Reduction in Absolute Neutrophil Counts in Patient on Clozapine Infected with COVID-19
por: Ramli, Fitri Fareez, et al.
Publicado: (2021) -
Reasons for admission to a general medical hospital for patients
taking clozapine
por: Gee, Siobhan, et al.
Publicado: (2022) -
Clozapine and COVID-19
por: Silva, Edward, et al.
Publicado: (2020) -
Management of clozapine treatment during the COVID-19
pandemic
por: Gee, Siobhan, et al.
Publicado: (2020)